Tel: +31 88 9950600
About Batavia Biosciences
Batavia Biosciences Inc.
300 TradeCenter Drive Suite 6650
Woburn, MA 01801
+1 781 305 3921
15 articles about Batavia Biosciences
Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected Veeva Vault Quality Suite to optimize its global quality assurance (QA), unifying content, processes, and training management on a single platform.
Batavia Biosciences successfully manufactures IAVI’s Lassa fever vaccine candidate on innovative HIP-Vax platform to support Phase I clinical trials
Batavia Biosciences announces today that they have successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa fever vaccine candidate, rVSV∆G-LASV-GPC.
Batavia Biosciences to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
Today, Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering.
6/18/2020Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
The Wistar Institute and Batavia Biosciences Launch Collaboration to Manufacture and Distribute Wistar’s Rubella Vaccine Globally
The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines
IAVI and Batavia Biosciences Announce Collaboration on VSV-vector Based Epidemic Preparedness Vaccines
Mutual expertise drives innovations to address supply issues for vaccines for outbreak pathogens
9/5/2019Companies from across Europe and Asia share updates on their business and pipelines.
Batavia Biosciences to deploy Horizon Discovery’s CHO cell technology to develop anti-Zika biotherapeutic with Vanderbilt University Medical Center and IDBiologics
Batavia Biosciences announced that the company has signed a license agreement to utilize Horizon Discovery’s GS knockout CHO K1 cell line expression system for the development of high yield antibody-expressing cell lines.
Batavia Biosciencesannounces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine.
The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been eradicated.
Batavia Biosciences Expands Its Viral Vector And GMP Facilities To Accommodate Increasing Market Demand
Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand.